HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

DLRNLCLFSYHRLRDLL gp160(759-775) human epitope
      LFSYHRLRDLLLIVTRIV gp160(765-782) human epitope
      LFSYHRLRDLLLIVTRIV gp160(765-782) human epitope
      LFrYHRLRDLLLIVTRIV gp160(765-782) observed variant
      LFSYHRLRDLLLIVARIV gp160(765-782) human epitope
        SYRRLRDLL gp160(767-775) A*24:02 human epitope
        SYHRLRDFI gp160(767-775) H-2Kd mouse epitope
        SYHRLRDFv gp160(767-775) susceptible form
        SYHRLRDcI gp160(767-775) diminished response
        SYHRLRDll gp160(767-775) diminished response
        SYHRLRDlI gp160(767-775) diminished response
        SYrhLRDFI gp160(767-775) non-susceptible form
        iYHhLRDll gp160(767-775) non-susceptible form
        SYrlLRDll gp160(767-775) non-susceptible form
        SYHRLRDFI gp160(767-775) H-2d human, mouse epitope
        SYHRLRDLLLIVTR gp160(767-780) A3, A31 human epitope
        SYHRLRDLLLIVTR gp160(767-780) A31 human epitope
         YHQLRDFILIVARTV gp160(768-782) A*03:01, A*31:01 human epitope
         YHrLRDFllIVtRTV gp160(768-782) non-susceptible form
          HRLRDLLLI gp160(769-777) B*27:02 human epitope
          HRLRDLLLI gp160(769-777) B*27:05 human epitope
          HRLRDLLLI gp160(769-777) human epitope
           RLRDLLLIV gp160(770-778) A*02 human epitope
           RLRDLLLIV gp160(770-778) A*02:01 human epitope
           RLRDLLLIV gp160(770-778) A*02:01 human epitope
           RLRDLLLIV gp160(770-778) A2 transgenic mouse epitope
           RLRDLLLIV gp160(770-778) human epitope
           RLRDLLLIVTR gp160(770-780) A*03 human epitope
           RLRDLLLIVTR gp160(770-780) A*03 human epitope
           RLRDLLLIVTR gp160(770-780) A*03 human epitope
           RLRDLLLIVTR gp160(770-780) A*03 human epitope
           RLRDLLLIVTR gp160(770-780) A*03 human epitope
           RLRDLLLIVTR gp160(770-780) A*03:01 human epitope
           RLRDLLLIVTR gp160(770-780) A*03:01 human epitope
           RLRDLLLIVTR gp160(770-780) A*03:01 human epitope
           RLRDLLLIVTR gp160(770-780) A3 human epitope
           RLRDfiLIVTR gp160(770-780) diminished response; subtype-specific susceptible form
           SLRDLLLIVTR gp160(770-780) diminished response; subtype-specific susceptible form
           RLRDLLLIVTR gp160(770-780) A3 human epitope
           RLRDLLLIiTR gp160(770-780) observed variant
           RLRDLLLvVTR gp160(770-780) observed variant
           RLRDLLLIVTR gp160(770-780) A3 human epitope
           RLRDLLLIVTR gp160(770-780) A3 human epitope
           RLRDLLLIVTR gp160(770-780) A3, A31 human epitope
           RLRDLLLIVTR gp160(770-780) A3, A31 human epitope
           RLRDLLLIVTR gp160(770-780) A3, A31 human epitope
           RLRDLLLIVTR gp160(770-780) A*31 human epitope
           RLRDLLLIVTR gp160(770-780) A31 human epitope
           RLRDLLLIVTR gp160(770-780) A31 human epitope
           RLRDLLLIVTR gp160(770-780) A31 human epitope
           RLRDLLLIVTR gp160(770-780) A*31:01 human epitope
           RLRDLLLIVTR gp160(770-780) A*31:01 human epitope
           RLRDLLLIVTR gp160(770-780) A*34 human epitope
           RLRDLLLIVTR gp160(770-780) A*74 human epitope
           RLRDLLLIVTR gp160(770-780) human epitope
           RLRDLLLIVTR gp160(770-780) human epitope
              DFILIVARTVELLGH gp160(773-787) A*68:02 human epitope
              DFILIVtRiVELLGH gp160(773-787) non-susceptible form
                  IVTRIVELL gp160(777-785) A*02:05 human epitope
                  IVTRIVELL gp160(777-785) A68 human epitope
                  IVTRIVELL gp160(777-785) A*68:02 human epitope
                  IVTRIVELL gp160(777-785) B*15:17 human epitope
                  IVTRIVELL gp160(777-785) B*40 human epitope
                  IVTRIVELL gp160(777-785) C*01 human epitope
                  IVTRIVELL gp160(777-785) C*18 human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health